Table 2 Multivariate logistic regression model-risk factors for PHH treatment or infant death.
Risk | Odds ratio (95% wald confidence limits) | p value | |
|---|---|---|---|
Maternal characteristics | |||
Maternal race/Ethnicity | 0.0014 | ||
Race asian/Pacific Islander vs. Hispanic | 1.150 (0.878–1.507) | ||
Black vs. Hispanic | 1.131 (0.894–1.431) | ||
Other vs. Hispanic | 1.025 (0.675–1.557) | ||
Non-Hispanic White vs. Hispanic | 1.570 (1.271–1.940) | ||
Multiple births or gestation | 1.265 (1.047–1.529) | 0.0150 | |
Cesarean delivery | 1.500 (1.261–1.783) | 0.002 | |
Antenatal magnesium sulfate Yes vs. No | 0.766 (0.651–0.901) | 0.0013 | |
Infant characteristics | |||
Female sex | 0.840 (0.716–0.986) | 0.0330 | |
Gestational age, weeks | |||
22–<24 vs. 30–<32 | 11.318 (7.563–16.937) | <0.0001 | |
24−<26 vs. 30-<32 | 6.049 (4.156–8.804) | ||
26−<28 vs. 30−<32 | 3.476 (2.367–5.104) | ||
28−<30 vs. 30−<32 | 1.848 (1.220–2.798) | ||
Birth location, outborn | 1.682 (1.383–2.046) | 0.014 | |
Early postnatal characteristics | |||
Delivery room interventions | |||
CPR: Cardiac compression or epinephrine | 1.600 (1.270–2.015) | <0.0001 | |
Hypothermic (<36 °C) | 1.670 (1.264–2.207) | 0.0003 | |
Patent ductus arteriosus | 0.524 (0.437–0.629) | <0.0001 | |
NSAID exposure | 0.649 (0.535–0.787) | <0.0001 | |
Birth hospital characteristics | |||
CPQCC region | <0.0001 | ||
1 vs. 11 | 2.707 (1.779–4.115) | ||
2 vs. 11 | 1.070 (0.747–1.534) | ||
3 vs. 11 | 1.361 (0.958–1.934) | ||
4 vs. 11 | 1.644 (1.116–2.423) | ||
5 vs. 11 | 1.403 (1.027–1.919) | ||
6 vs. 11 | 1.489 (1.106–2.005) | ||
7 vs. 11 | 1.271 (0.814–1.985) | ||
8 vs. 11 | 1.025 (0.741–1.416) | ||
9 vs. 11 | 2.410 (1.618–3.591) | ||
10 vs. 11 | 1.552 (1.038–2.320) | ||
AAP level NICU (2016 designation) | 0.0010 | ||
II vs. IV | 0.548 (0.371–0.810) | ||
III vs. IV | 0.695 (0.570–0.847) |